Tag: Psychedelic Therapies
PSYC Enters Joint Venture Partnership with Minerco, Inc.
Hollister Biosciences Inc. Commends the State of Arizona for starting Adult-Use Cannabis Sales ahead of schedule, Venom Extracts it’s 100% owned subsidiary is a category leader with over 4 million grams sold throughout the state in 2020
Core One Labs Announces Vocan Assembles Equipment to Produce Biosynthesized Psilocybin
Revive Therapeutics Included in First Psychedelic Exchange Traded Fund
Entheon Biomedical to be Included in First North American Psychedelic ETF
Empower Clinics Doubling KAI Medical Laboratory Size In Anticipation Of Test Volumes By End Of Q1. Files MDEL Application With Health Canada To Import and Sell KAI Saliva PCR Test In Canada
Novamind Expands Psychedelic Medicine Access in Utah
